Minerva Neurosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $106.0M | $83.0M |
| FY2017 | — | $131.6M | $26.1M |
| FY2018 | — | $90.3M | $50.2M |
| FY2019 | — | $27.8M | $21.4M |
| FY2020 | — | $52.7M | $25.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $106.0M | $83.0M |
| FY2017 | — | $131.6M | $26.1M |
| FY2018 | — | $90.3M | $50.2M |
| FY2019 | — | $27.8M | $21.4M |
| FY2020 | — | $52.7M | $25.4M |